ASHG 2009: Achieving Genome-Wide Success from SNPs to CNVs to eQTL

Presenter: Dr. Christophe Lambert, Golden Helix CEO and Co-Chair of the FDA MAQC CNV Team

Date: October 22, 2009

Duration: 77 Minutes

ACCESS THIS WEBCAST:

Abstract

The following recording is from the Golden Helix ancillary event hosted in conjunction with the 2009 American Society of Human Genetics annual meeting. Dr. Christophe Lambert, CEO of Golden Helix, examines best practices, pitfalls, and analytic methods learned from over 30 genome-wide SNP, CNV, and eQTL association studies. Topics include study design, plating strategies, quality assurance on samples and markers, batch effect correction, identification of rare variants, and more.

About the Presenter

Dr. Christophe Lambert is the Chairman and CEO of Golden Helix, Inc., a bioinformatics company he founded in Bozeman, MT in 1998. Dr. Lambert graduated with his Bachelors in Computer Science from Montana State University in 1992 and received his Ph.D. in Computer Science from Duke University in 1997. Dr. Lambert is also currently the co-chair of the Food and Drug Administration’s Genome Wide Copy Number Variation Data Analysis Team of the Microarray Quality Control Consortium.